Showing results (391-400 of 4,868) with videos related to

Sort By:
Pageof 487
Urologic Oncology|December 13, 2003
Histologic confirmation of lesions identified by Prostascint scan following definitive treatmentCarlos E Bermejo, John Coursey, Joseph Basler, et al.
Urologic Oncology|December 13, 2003
Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicityJohn S Lam, Mitchell C Benson, Michael A O'Donnell, et al.
Urologic Oncology|December 13, 2003
The utility of apical anterior horn biopsies in prostate cancer detectionMaxwell V Meng, Joseph H Franks, Joseph C Presti, et al.
Urologic Oncology|December 25, 2003
Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or lessDavid S DiMarco, Michael L Blute, Horst Zincke, et al.
Urologic Oncology|July 1, 2019
The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: A systematic reviewTakehiro Iwata, Shoji Kimura, Mohammad Abufaraj, et al.
Urologic Oncology|July 1, 2019
Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancerTakehiro Iwata, Shoji Kimura, Mohammad Abufaraj, et al.
Urologic Oncology|June 27, 2019
Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomesKhadijah A Mitchell, Heinric Williams
Urologic Oncology|July 10, 2019
Comparative effectiveness of treatments for high-risk prostate cancer patientsRavishankar Jayadevappa, David I Lee, Sumedha Chhatre, et al.
Urologic Oncology|July 10, 2019
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysisMadhur Nayan, Shreya Jalali, Anil Kapoor, et al.
Urologic Oncology|October 12, 2019
Combined clinical characteristics and multiparametric MRI parameters for prediction of cribriform morphology in intermediate-risk prostate cancer patientsJie Gao, Qing Zhang, Yao Fu, et al.
Pageof 487